Two trends, one growing financial impact
The biggest pharmacy cost challenges don't come from just one place. High-cost cell and gene therapies can create significant financial risk when a single member requires treatment, while everyday prescription medications add up quickly across a large population. Together, these two ends of the pharmacy spectrum play a major role in shaping overall employer spend.

Two trends, one growing financial impact
Scripta specializes in pharmacy savings, helping employers uncover opportunities to reduce prescription drug spend while ensuring members receive effective, clinically sound treatment options. Their approach combines advanced analytics with personalized recommendations to drive meaningful savings.

Aradigm: Bringing rare, complex healthcare conditions to light
Aradigm specializes in helping employers better manage specialty pharmacy costs, one of the fastest-growing drivers of healthcare spend. By combining data insights with clinical oversight, they help ensure members receive the right treatment while supporting cost-effective outcomes.

The big questions, answered
Watch the panel
